Apoptosis (the 1992 frank rose memorial lecture)

British Journal of Cancer

Volumn 67, Issue 2, 1993, Pages 205-208

  Wyllie, A H ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GROWTH FACTOR; PROTEIN P53;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CHEMOSENSITIVITY; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; ONCOGENE C MYC; ONCOGENE RAS; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; HUMAN;

EID: 0027479796     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.40     Document Type: Article

References (61)

1. ARENDS, M.J., MORRIS, R.J. & WYLLIE, A.H. (1990). Apoptosis: the role of the endonuclease. Am. J. Pathol., 136, 593-608.
2. ARENDS, M.J. & WYLLIE, A.H. (1991). Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Path., 32, 223-254.
3. BERTRAND, R., SARANG, M., JENKIN, J., KERRIGAN, D. & POMMIER, Y. (1991). Differential induction of secondary DNA fragmentation by topo-isomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res., 51, 6280-6285.
4. BISSONNETTE, R.P., ECHEVERRI, F., MAHBOUBI, A. & GREEN, D.R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 359, 552-554.
5. BUTTYAN, R., OLSSON, C A., PINTAR, J., CHANG, C., BANDYK, M., NG, P.Y. & SAWCZUK, I.S. (1989). Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mole. & Cell. Biol., 9, 3473-3481.
6. BUTTYAN, R., ZAKERI, Z., LOCKSHIN, R. & WOGLEMUTH, D. (1988). Cascade induction of c-fos, c-myc and heat shock protein 70K transcripts during regression of rat ventral prostate gland. Mole. Endocrinol., 11, 650-656.
7. CLARK, H.M., JONES, D.B. & WRIGHT, D.H. (1992). Cytogenetic and molecular studies of t(14;18) in nodal and extranodal B-cell lymphoma. J. Pathol., 166, 129-137.
8. DIVE, C. & WYLLIE, A.H. (1992). Apoptosis and cancer chemotherapy. In Hickman, J.A. & Tritton, T.T. (eds) Frontiers in Pharmacology: Cancer Chemotherapy. Blackwell Scientific: Oxford (in press).
9. DUVALL, E., WYLLIE, A.H. & MORRIS, R.G. (1985). Macrophage recognition of cells undergoing programmed cell death. Immunology, 56, 351-358.
10. DYSON, J.E.D., SIMMONS, D.M., DANIEL, J., MCLAUGHLIN, J.M., QUIRKE, P. & BIRD, C.C. (1986). Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell & Tissue Kinetics, 19, 311-324.
11. EASTMAN, A. (1990). Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280.
12. EVAN, G.I., WYLLIE, A.H., GILBERT, C.S., LITTLEWOOD, T.D., LAND, H., BROOKS, M., WATERS, C M., PENN, L.Z. & HANCOCK, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-129.
13. FANIDI, A., HARRINGTON, E.A. & EVAN, G.I. (1992). Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359, 554-556.
14. FESUS, L., DAVIES, P.J.A. & PIACENTINI, M. (1991). Molecular mechanisms in the program of cell death by apoptosis. Eur. J. Cell Biol., 56, 170-177.
15. FESUS, L., THOMAZY, V., AUTUORI, F., CERU, M.P., TARCSA, E. & PIACENTINI, M. (1989). Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett., 245, 150-154.
16. GOING, J.J., ANDERSON, T.J. & WYLLIE, A.H. (1992). Ras p21 in breast tissue: association with pathology and cellular localisation. Br. J. Cancer, 65, 45-50.
17. GREGORY, CD., DIVE, C., HENDERSON, S., SMITH, C.A., WILLIAMS, G.T., GORDON, J. & RICKINSON, A.B. (1991). Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature, 349, 612-614.
18. HENDERSON, S., ROWE, M., GREGORY, C.D., CROOM-CARTER, D., WANG, F., LONGNECKER, R., KIEFF, E. & RICKINSON, A.B. (1991). Induction of bcl-2 expression by Epstein Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115.
19. HOCKENBERRY, D., NUNEZ, G., SCHREIBER, R.D. & KORSMEYER, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
20. HOCKENBERRY, D.M., ZUTTER, M., HICKEY, W., NAHM, M. & KORSMEYER, S.J. (1991). Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl Acad. Sei. USA, 88, 6961-6965.
21. IJIRI, K. & POTTEN, C.S. (1987). Further studies on the response of intestinal crypt cells of different hiearchical status to eighteen different cytotoxic agents. Br. J. Cancer, 55, 113-123.
22. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S.-I., SAMESHIMA, M., ITASE, A., YOSHIYUKI, S. & NEGATA, S. (1991). The polypeptide encoded by the cDNA of human cell surface antigen fas can modulate apoptosis. Cell, 66, 233-243.
23. KASTAN, M.B., OHYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. & CRAIG, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
24. KERR, J.F.R., SEARLE, J., HARMON, B.V. & BISHOP, C.J. (1987). Apoptosis. In Perspectives on Mammalian Cell Death. Potten, C.S. (ed.) Oxford Science Publications: Oxford, p. 93-128.
25. KERR, J.F.K., WYLLIE, A.H. & CURRIE, A.H. (1972). Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br. J. Cancer, 26, 239-245.
26. KOURY, M.J. & BONDURANT, M.C. (1990). Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science, 248, 378-381.
27. KYPRIANOU, N., ALEXANDER, R.B. & ISAACS, J.T. (1991a). Activation of programmed cell death by recombinant human tumour necrosis factor plus topoisomerase II-targeted drugs in L929 tumor cells. J. Natl Cane. Inst., 83, 346-350.
28. KYPRIANOU, N., ENGLISH, H.F., DAVIDSON, N.E. & ISAACS, J.T. (1991b). Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166.
29. KYPRIANOU, N., ENGLISH, H.F. & ISAACS, J.T. (1990). Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753.
30. LASTER, S.M., WOOD, J.G. & GOODING, L.R. (1988). Tumour necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol., 141, 2629-2634.
31. LENNON, S.V., MARTIN, S.J. & COTTER, T.G. (1990). Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli. Biochem. Soc. Trans., 18, 343.
32. LEVINE, A.J., MOMARD, J. & FINLAY, C.A. (1991). The p53 tumour suppressor gene. Nature, 351, 453-456.
33. LIU, Y.J., JOSHUA, D.E., WILLIAMS, G.T., SMITH, C.A., GORDON, J. & McCLENNAN, I.C.M. (1989). The mechanisms of antigen-driven selection in germinal centres. Nature, 342, 929-931.
34. MCCONKEY, D.J., NICOTERA, P., HARTZELL, P., BELLOMO, G., WYLLIE, A.H. & ORRENIUS, S. (1989a). Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic calcium concentration. Arch. Biochem. & Biophys., 269, 365-370.
35. MARTIKAINEN, P., KYPRIANOU, N., TUCKER, R.W. & ISAACS, J.T. (1991). Programmed cell death of nonproliferating androgenindependent prostatic cancer cells. Cancer Res., 51, 4693-4700.
36. MARTIN, D.P., SCHMIDT, R.E., DISTEFANO, P.S., LOWRY, O.H., CARTER, J.G. & JOHNSON, E.M. (1988). Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol., 106, 829-844.
37. MONPETIT, M L., LAWLESS, K.R. & TENNISWOOD, M. (1986). Androgen-repressed messages in the rat ventral prostate. The Prostate, 8, 25-30.
38. MOORE, J.V. (1987). Death of cells and necrosis of tumours. In Potten, C.S. (ed.) Perspectives in Mammalian Cell Death. Oxford: Oxford University Press, p 295-325.
39. NUNEZ, G., HOCKENBERRY, D., MCDONNELL, T.J., SORENSEN, C.M. & KORSMEYER, S.J. (1991). Bcl-2 maintains B cell memory. Nature, 353, 71-73.
40. NUNEZ, G., LANDON, L., HOCKENBERRY, D., ALEXANDER, M., MCKEARN, J.P. & KORSMEYER, S.J. (1990). J. Immunol., 144, 3602.
41. OWENS, G.P., HAHN, W. & COHEN, J.J. (1991). Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol. & Cell. Biol., 11, 4177-4188.
42. PIACENTINI, M., AUTOUORI, F., DINI, L., FARRAEE, M.G., GHIBELLI, L., PIREDDA, L. & FESUS, L. (1991). Tissue transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor stimulation. Cell Tissue Res., 263, 227-235.
43. RAFF, M. (1992). Solid controls on cell survival and cell death. Nature, 356, 397-400.
44. SARRAF, C.E. & BOWEN, I.D. (1988). Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell & Tissue & Kinetics, 21, 45-49.
45. SAVILL, J.S., DRANSFIELD, I., HOGG, N. & HASLETT, C. (1990). Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature, 343, 170-173.
46. SAVILL, J.S., WYLLIE, A.H., HENSON, J.E., WALPORT, HENSON, P.M. & HASLETT, C. (1989). Macrophage phagocytosis of aging neutrophils inflammation. Programmed cell death in the neutrophil leads to recognition by macrophage. J. Clin. Invest., 83, 865-875.
47. SEARLE, J., LAWSON, T.A., ABBOTT, P.J., HARMON, B.V. & KERR, J.F.R. (1975). An electom microscopy study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol., 116, 129-138.
48. SENTMAN, C.L., SHUTTER, J.R., HOCKENBERG, D., KANAGAWA, D., & KORSMEYER, S.J. (1991). bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
49. SMITH, C.A., WILLIAMS, G.T., KINGSTON, R., JENKINSON, E.J. & OWEN, J.J.T. (1989). Antibodies to CD3/T receptor complex induce cell death by apoptosis in immature thymic cultures. Nature, 337, 181-184.
50. STRASSER, A., HARRIS, A.W. & CORY, S. (1991). bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889-899.
51. SZENDE, B., ZALATINI, A. & SCHALLY, A.W. (1989). Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proc. Natl Acad. Sci., 86, 1643-1647.
52. TRAUTH, B.C., KLAS, C., PETERS, A.M., MATZKU, S., MOLLER, P., FALK, W., DEBATIN, K.M. & KRAMER, P.H. (1989). Monoclonal antibody-mediated tumour regresssion by induction of apoptosis. Science, 245, 301-305.
53. WILCOCK, C. & HICKMAN, J.A. (1988). Characterisation of a Na+/K+/C1” cotransporter in alkylating agent-sensitive L1210 murine leukemia cells. Biochim. Biophys. Acta, 946, 359-367.
54. WILLIAMS, A.R.W., PIRIS, J., SPANDIDOAS, D A. & WYLLIE, A.H. (1985). Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br. J. Cancer, 52, 687-693.
55. WILLIAMS, G.T., SMITH, C.A., SPOONCER, E., DEXTER, T.M. & TAYLOR, D.R. (1990). Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343, 76-78.
56. WYLLIE, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
57. WYLLIE, A.H., KERR, J.F.R. & CURRIE, A.R. (1980). Cell death: the significance of apoptosis. Intern. Rev. Cytol., 68, 251-306.
58. WYLLIE, A.H. & MORRIS, R.G. (1982). Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Amer. J. Pathol., 109, 78-87.
59. WYLLIE, A.H., MORRIS, R.G., SMITH, A.L. & DUNLOP, D. (1984). Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol., 142, 67-77.
60. WYLLIE, A.H., ROSE, K.A., MORRIS, R.G., STEEL, C M., FOSTER, E. & SPANDIDOS, D.A. (1987). Rodent fibroblast tumours expressing myc and ras genes. Growth, metastasis and endogenous oncogene expression. Br. J. Cancer, 56, 251-259.
61. YONISH-ROUACH, E., RESNITSKY, D., LOTEM, J., SACHS, K., KIMCHI, A. & OREN, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.